Metraipolis › archive › dc_c49458dad5e2

The Cancer Immunotherapy Thromboembolism Assessment: A Novel Score for Predicting Thromboembolic Events in Melanoma Patients Treated With Immune Checkpoint… — Europe PMC PMID:42041031

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42041031
DOI
10.1002/ijc.70523
License (as archived)
solo-consultazione
Archived
2026-11-03T04:22:22.089Z
SHA-256 of the archived text
6b452e5456088150a94616d551911a7e8504177a555e38dc79be2ef38a51eca7
Stable URL of this page
https://metraipolis.com/documento/dc_c49458dad5e2

How to cite

The Cancer Immunotherapy Thromboembolism Assessment: A Novel Score for Predicting Thromboembolic Events in Melanoma Patients Treated With Immune Checkpoint… — Europe PMC PMID:42041031 — Europe PMC (en), https://europepmc.org/article/MED/42041031 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c49458dad5e2 (Metraipolis archive dc_c49458dad5e2, sha256 6b452e5456088150a94616d551911a7e8504177a555e38dc79be2ef38a51eca7)
BibTeX
@misc{dcc49458dad5e2,
  title = {The Cancer Immunotherapy Thromboembolism Assessment: A Novel Score for Predicting Thromboembolic Events in Melanoma Patients Treated With Immune Checkpoint… — Europe PMC PMID:42041031},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42041031},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c49458dad5e2; sha256 6b452e5456088150a94616d551911a7e8504177a555e38dc79be2ef38a51eca7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42041031. Agents can read the archived copy with the MCP tool read_document.